8th BioMarine International Business Convention
1-3 oct 2017, Rimouski Qc, Canada View Location

Preliminary Program

Message from BioMarine Québec 2017 Program Committee

Science and technology continue to move forward in making different technological tools, methods and processes to develop new uses and products from marine biological resources. Numerous and different marine biotechnological products are under development or have been commercialized, ranging from novel drugs, new food components, innovative chemicals, enzymes, active ingredients, up to bioenergy. The BioMarine 2017 program will focus on the plentiful of opportunities and the various applications arising from marine biotechnology for aquaculture and animal health, pharmaceutical and biomedical biomaterials and molecules, nutraceuticals and food added value ingredients, active extracts and components for cosmetic and personal care products , horticultural and agricultural uses and for environmental, maritime and industrial applications

Version Française

La science et la technologie continuent d’aller de l’avant pour l’obtention de différents outils technologiques, méthodologies et procédés pour le développement de nouveaux usages et produits à partir de des ressources biologiques marines. Un grand nombre de produits sont en cours de développement ou ont été commercialisés, allant des nouveaux médicaments, de nouveaux produits chimiques, des enzymes, des composantes d’aliments, d’ingrédients actifs jusqu’aux bioénergies. Le programme de BioMarine 2017 sera axé sur l’abondance d’opportunités et les applications variées découlant des biotechnologies marines pour l’aquaculture et la santé animale, les actifs pharmaceutiques et les matériaux biomédicaux, les nutraceutiques et les ingrédients alimentaires à valeur ajoutée, les extraits et composantes pour les produits cosmétiques et de soins personnels, les nouveaux usages horticoles et agricoles et pour les applications environnementales, maritimes et industrielles.

Preliminary Grid

*Access to BioMarine area for registered delegates only – **Access to MyBlueCity for all

web-prog-jan17

October 1, 2017

09:00-10:30 BICA General Assembly
15:30-16:00 Official inauguration of MyBlueCity in presence of official Quebec representatives and HSH Prince Albert 2 of Monaco
17:00-18:00 BioMarine Opening Plenary open to Public and BioMarine delegates
18:15-19:00 Welcome Reception hosted by the City of Rimouski

October 2 – 3, 2017 – Program BioMarine workshops and MyBlueCity agora:

Remark: our program committee wishes to offer an open and trans-sector discussion involving all key components from our biomarine industry. Therefore, the program we are currently elaborating may evolve slightly in the coming months.  The main objective is to really engage with the audience and make sure that some recommendations could emerge from the debate we will organize around each theme.

BIOMARINE WORKSHOPS:

click for workshop’s content

Theme 1 : Animal health and aquaculture

BioMarine always privileges the trans-sectoral approach, and this is particularly the case for human nutrition. Particular attention will be given to animal health and aquaculture:
– The animal health market includes products such as vaccines, antibiotics, antifungals, and food additives for the improvement of the quality of global life and productivity. 40% of this market concerns pets, with the medicalization aspect greatly intensifying (notably for treatment of obesity, arthritis, cancer, etc.). The other 60% of the market, essentially concerning farmed animals (cattle, pigs and poultry, but also rabbits, horses, lamas and ostriches), is a fast growing market due to the rising global demand for protein.

– Natural ingredients in the marine sector are seen as an interesting alternative to antibiotics. The alginates and carrageenan of algae are used as wetting agents and fillers in the cast. An explored avenue focuses on algae for carotenoids, polyunsaturated fatty acids and other components. Technological innovations, contributing significantly to aquaculture production, will also help this sector to meet the growing demand for high quality products. The aquaculture sector also includes marine, plant and animal ingredients and food additives. Those materials are designed to increase the production of aquaculture in a sustainable way by improving the rate of growth, reproduction, and disease resistance. Aquaculture as a means to “cultivate” marine organisms is considered to be a fantastic sustainable source of so-called opportunity…

The global animal health market is estimated at $20 billion . The animal world drug market is expected to reach $42.9 billion by 2018, because of health needs and the growing need for a durable supply food for the human population. Aquaculture complements this sector as a supplementary source of protein necessary food needs of a growing world population – and we particularly believe that the ingredients for aquaculture food market are one of the most interesting areas. It reached revenues of more than $28.5 billion by 2011 and could reach $53.6 billion in 2018.

Theme 2: Industrial biotech and processes

Bio-products and bio-processes support sustainable economic development. Bio-products are defined as industrial products that require renewable agricultural, marine or forestry materials for obtaining biofuels, industrial chemicals, textiles, bio-plastics, or enzymes. This market presents many opportunities for growth and develops a bio-refinery approach.

The exploitation of microalgae, marine microorganisms and seaweed is the approach that is most compatible with the development of industrial bio-products. Several directions and innovation initiatives are in support of the development of this axis of market by exploiting these resources ranging from convenience products to the anti-fouling substances as well as the enzymes and the microorganisms themselves.

A new BBC research report, “Biorefinery Products: Global Markets”, revealed that the global market for bio-products is expected to grow to $700.7 billion by 2018, with a five-year compound annual growth rate of 5.5%. The non-energetic market, the fastest growing segment overall, is moving at a tremendous 14.9% CAGR. The non-energetic bio-products category, which includes chemicals, pharmaceuticals and materials, is the largest and fastest moving segment in this market and is expected to reach $472.8 billion by 2018, up from $236.3 billion in 2013.

The session will discuss the important development associated to the bio-refinery industry, including the inevitable discussion about international product validation and regulatory aspects. National and international agencies play a key role in the protection of consumers and the environment, while allowing SMEs to develop internationally.

Theme 3: Agriculture and horticulture

Development trends focus on ecological agriculture with the development of bio‐insecticides and other green components for agricultural applications. Marine biotechnology however can deliver alternative plant products and chemicals from marine biomass by-products, macroalgae, marine microorganisms and microalgae for fertilizer, herbicides, insecticides and beneficial health properties of plants. The global market for agricultural biotechnology was estimated at $ 8 billion in 2010.

Despite the controversy surrounding genetically modified foods, agricultural biotechnology market will continue to witness strong growth over the next five years. Due to the constant reduction of arable land and the reduction in the productivity of agricultural land, the market of plant protection products for world agriculture exceeded $329 billion in 2015.

The environmental component has become a fundamental issue. We will of course discuss the regulatory and the legal aspects that companies must anticipate if they wish to have their products adopted in different geographical zones.

Theme 4: Healthcare and biomedical

The rapid increase in age-related chronic diseases is one of the engines of growth in this sector. Innovative products are expected to be launched for patients with cancer, diabetes, thrombosis and for debilitating diseases of the system central nervous. Between 2010‐2015, anti-cancer drugs (antitumor, immunomodulators) show the highest growth rate of all therapies. The musculoskeletal system, systemic anti‐infectious, biomaterials and micro surgery, drugs and medicines for the respiratory system also displayed significant growth rates over the period 2010‐2015.

The bio-active substances related to health are the most important market segment of marine biotechnology. Several marine ingredients are known for their anticancer, antibiotic and anti‐inflammatory properties. All major pharmaceutical companies including Merck, Lilly, Pfizer, Hoffman‐Laroche, and Bristol‐Myers Squibb have departments of marine biotechnology. Finding a bioactive molecule is only the beginning of the work. There are several important steps to take before you can register a new drug, among which are the stability, safety and quality of the molecule as well as various clinical trials. This process is long (between 10 and 20 years) and costly (various estimates place the cost between 500 million and $1 billion).

Pharmaceutical biotechnology and healthcare have achieved global revenues of $115 billion in 2006 and the growth is expected to be even faster in the years to come.

The session will discuss the potential of marine ingredients in this segment and how natural compounds could be an alternative to the one coming from pure synthesis.

Theme 5: Nutraceuticals, nutrition and innovative food

In recent years, the pharmaceutical and food sectors have become interested in the benefits of dietary an food supplements. The ageing of world populations and the increase in healthcare costs has encouraged consumers and doctors to turn towards supplements. A study estimated that 70% of Americans over the age of 25 are consuming these products. The reduction of cholesterol levels, control of blood glucose, obesity, cardiovascular and inflammatory diseases are the most important targets. The niche of “high quality” proteins and peptides associated with weight management is also an area of interest.

Substances derived from botanical extracts and substances of marine origin constitute the fastest growth among key groups of nutraceutical ingredients. Given the context of overexploitation of living marine resources, better use of biomass of fish and seafood is targeted for this sector. Aquaculture production is also eyed by this sector. One of the most promising trends will be the production of marine bio‐ingredients using enzymatic hydrolysis. Worldwide market, by 2020, it is estimated that 50% of the value-added marine (fish oil, omega‐3, proteins) will come of co-products and that these products are going to come more and more species of breeding.

Transparency Market Research mentions that the global nutraceutical market should reach $204.8 billion? in 2017, with a CAGR of 6.3%. In 2017, the Asia Pacific region should become the second largest market after North America. North America has the highest market share for products nutraceuticals, valued at $56.4 billion in 2011.

We have said a lot concerning the utilization of marine ingredients in the sector, but this session will concentrate on the new trends and important regulatory issues. For instance what are the bottlenecks that SMEs are facing when they wish to reach the market with a new natural ingredient?

Theme 6 : Cosmetics and personal care

The global opportunities are moving towards antiaging products and skin care. An integrated health and beauty industry can be achieved by involving the sustainable use of natural ingredients whose virtues are scientifically proven. The cosmetics industry is increasingly turning towards the oceans in search of new ingredients. Several major cosmetics companies already use molecules of marine origin in their products. The ingredients from coastal plants and algae, proteins, and the marine minerals are particularly appreciated by natural brands looking for new sources of innovation. Algae, rich in vitamins, minerals and rheological agents become a frequent source of assets anti‐age.

The global market for beauty and personal care industry has increased by 36% in 2005‐2010 to reach $382,3 billion in 2011. Despite current global economic trends, this industry still shows stable growth, notably in emerging markets such as Asia‐Pacific and America.

The session will discuss the utilization of marine ingredients in the cosmetic market. We will also try to understand the new trends of “cosmeticals”. Is it only a temporary buzz or can we anticipate a real market opportunity? What are the facts and what will be the role of pharmaceuticals companies in this emerging sector? Is there a risk for existing cosmetic companies and ingredients providers? Are we facing a series or mergers if the market is developing?

Theme 7: Space and technology to improve ocean and coastal zone monitoring

Securing biodiversity as well as the protection and conservation of ecosystems are of critical importance. The combination of various resolution levels of satellite sensors with organizational levels of ecosystems is one of the main ideas of applying earth observations in monitoring of oceans and coastal zones. Satellite imagery is perhaps the best source of monitoring biodiversity status, especially over large areas. Observations need to be extensive, regular and consistent to establish baselines and trends which is what satellite-based sensors can do the best. Most satellite observations, however, still have limited coverage and compatibility, because they are controlled by the diverse objectives of national space programmes. In many cases, satellite data are restricted or are not freely available.

The session will discuss the contribution of space technology to improve ocean and coastal zone monitoring. Fisheries and commercial aquaculture could seize this opportunity: What are the recent developments in the field? What are the associated costs and will the industry adopt this new technology?

Theme 8: Arctic marine resources sustainable development

Global interest in economic development in the Arctic has been growing rapidly. This has been driven by both supply and demand shifts for the resources and amenities produced in the Arctic. On the costs side, there is a perception that climate-change driven impacts in the Arctic will reduce ice cover (both sea-ice and land-fast ice) in the area and therefore also impact costs of doing business. Simultaneously, global demand for these unique marine arctic resources is increasing as both population and wealth increase.
There currently exists a narrow window for using our increased understanding of economic transitions to smooth the disruption and minimize the direct and indirect costs of Arctic economic development.

In this session, we will discuss some aspects of the challenges to development, along with examples of tools for managing them in inclusive and sustainable ways. What role can mesopelagic resources play in the development of the Arctic? What are the challenges the industry will face? How can we harmonize the best practices to avoid any future claims? What is the outcome for indigenous populations? How can we make sure they will be part of the social economic equation?

 

MyBlueCity Agora :

AGORA 1: Blue employment

  1. potential of blue careers ( in Quebec/Canada/international)
  2. which country leads in terms of blue careers opportunities
  3. which sectors are employing the most

 

AGORA 2: Blue education

  1. are the diplomas adapted/in line with jobs requirements?
  2. which type of qualifications and skills do these blue careers require
  3. which future in blue careers for students with a non-technical background (law, social sciences, etc)

 

AGORA 3 : How to finance your blue project?

  1. from the idea to the financing, how long does it take?
  2. is there any banks or investor ready to support blue growth?
  3. which country offers the most valuable support?
  4. how to access public funding?
  5. how to structure my capital?
  6. equity, debt, mezzanine, IPO in a nutshell
  7. is my Board the right one for the next step?

 

AGORA 4: Is general public ready for the blue revolution?

  1. what is at stake?
  2. how to balance the views in order not to kill a growing industry?
  3. what is the understanding of public towards the blue growth?

The specific case of aquaculture:

  1. what is accepted or not?
  2. is there a clear message on risk / benefits?
  3. can NGOs and industry work together?

 

AGORA 5: Space contribution to ocean knowledge

  1. why is space is an important component of this blue industry?
  2. what is the real contribution?
  3. how we handle data and how can we model it?
  4. what price and services?

 

AGORA 6: The bioplastic revolution

  1. how can we reach the critical point: 35 % of starch coming from seaweeds?
  2. what is the key enabling technology to foster bioplastic developments?
  3. what is the consumer acceptance towards this innovation?
  4. what is the environmental benefit?

 

Join us now and participate in one of our workshops or agora debates!